Crosslink Therapeutics

Boston, MA · Founded 2022 · Privately Held (backing)

Operator of a biologics platform intended to enable targeted cancer treatment using tumor-specific biochemical markers. Crosslink Therapeutics is based in Boston, MA and was founded in 2022. It has raised $8 million across 1 recorded round; the latest was a $4.3 million seed round in Apr 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$8.0M
Last round
Seed Round
Apr 2025

Who backs Crosslink Therapeutics?

5 investors
InvestorType
Highlight CapitalOther
TIFF Investment ManagementFund of funds
Cure Ventures—
Rivas Capital—
Sigmas Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Crosslink Therapeutics investors

5 investors are on record for Crosslink Therapeutics, including Highlight Capital, TIFF Investment Management, Cure Ventures and Rivas Capital. The seed round in Apr 2025 drew 6 investors.

Free account
More of Crosslink Therapeutics with a free account
  • ·Watch Crosslink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Crosslink Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View